Aceragen logo

Aceragen

Aceragen is a rare disease company striving to restore a better life for patients and families.

2 employees · est. 2021 · Durham, United States

VS
Lumos Pharma logo

Lumos Pharma

Transforming Lives with Rare Focus

47 employees · est. 1999 · Austin, United States

Lumos Pharma is the older company (2021 vs 1999); Lumos Pharma is the larger of the two.

Side-by-Side Comparison

Aceragen Lumos Pharma
Founded
2021 1999 older
Headquarters
Durham, United States Austin, United States
Employees
2 47 larger
Industry
Biotechnology, Health Care, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Private Equity Series B
Total Funding
$35.00M $53.50M
Funding Rounds
1 3
Services
Not tracked yet Development of therapeutics for rare diseases, Clinical trials for growth deficiencies, Patient advocacy and compassionate use
Target Customers
Not tracked yet Patients with rare diseases, Families dealing with growth deficiencies, Healthcare providers, Biopharmaceutical partners
Taxonomy
Rare Diseases, Orphan Diseases, Biopharmaceutical, Therapeutic Treatments, Drug Development, Patient-centric, Community Awareness, Regulatory Outreach, Novel Therapies, Patient Advocacy Biopharmaceutical, Clinical-stage, Rare Diseases, Therapeutics, Pediatric Growth Hormone Deficiency, Oral Growth Hormone Therapy, LUM-201, Drug Development, Strategic Partnerships, Therapeutic Candidates, Portfolio Expansion, In-licensing, Creatine Transporter Deficiency, Technology Commercialization, Novel Treatment
Website
aceragen.com lumos-pharma.com
Aceragen logo

About Aceragen

Aceragen is a rare disease biopharmaceutical company founded in 2021 with a clear mission to address rare, orphan diseases with no available treatment. Their slogan, "Aceragen is a rare disease company striving to restore a better life for patients and families," reflects their commitment to improvi...

Lumos Pharma logo

About Lumos Pharma

Lumos Pharma, founded in 1999, is a clinical-stage biopharmaceutical company headquartered in the United States. Known for their slogan, "Transforming Lives with Rare Focus", the company is dedicated to developing new therapies for rare diseases, with a primary emphasis on high-need areas where ther...

We will tell you when either one moves

BounceWatch watches Aceragen and Lumos Pharma for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Aceragen and Lumos Pharma — by email.

Frequently Asked Questions

Aceragen — Aceragen is a rare disease company striving to restore a better life for patients and families.. Lumos Pharma — Transforming Lives with Rare Focus. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aceragen has raised $35.00M while Lumos Pharma has raised $53.50M.
Aceragen and Lumos Pharma operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aceragen with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aceragen on 12 Sep 2024, and Lumos Pharma on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy